A Study of AL8326 in Healthy Subjects

Clinical trial NCT07132957 · COMPLETED

Trial details

NCT number: NCT07132957
Sponsor: Advenchen Laboratories Nanjing Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Small Cell Lung Cancer Solid Tumors

Start date: 2025-02-21
Primary completion: 2025-05-17
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.